Condition
Severe Mood Dysregulation
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01714310Phase 2CompletedPrimary
Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation
NCT01962623Not ApplicableCompletedPrimary
Interpersonal Psychotherapy for Youth With Severe Mood Dysregulation
NCT01591564Not ApplicableCompletedPrimary
Interpersonal Psychotherapy in Youth With Severe Mood Dysregulation-Pilot
NCT00825552Not ApplicableUnknownPrimary
Pharmacological Treatment of Children and Adolescents With Severe Mood Dysregulation
Showing all 4 trials